OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.41 USD
+0.01 (0.71%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $1.41 0.00 (0.00%) 6:08 PM ET
4-Sell of 5 4
C Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
OPKO Health, Inc. [OPK]
Reports for Purchase
Showing records 21 - 40 ( 108 total )
Company: OPKO Health, Inc.
Industry: Medical - Instruments
ModeX Receives BARDA Contract For Multi-Specific Antibodies Against Viral Infections; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Once-Weekly Human Growth Hormone Analog Approved in the U.S.; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
License Agreement With Merck Inked for EBV Vaccine Candidate; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Full-Year 2022 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Advancing Diagnostics and Novel Pharmaceuticals; Initiating at Buy and $3 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OPKO Health, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department